Designing high efficiency glow discharge cleaning systems

In this paper we present our studies about the choices of anode design and operational regime in order to get high efficiency glow discharge cleaning of the first wall of a fusion device. We analyzed a database of toroidal and poloidal profiles of the ion current density at the wall, measured by electrostatic probes embedded in RFX-mod first wall tiles, taken in different configurations. The ion current at the wall, both global and local, is in fact strictly connected to the cleaning efficiency, since during glow discharge the wall is physically sputtered by the ions. We found that small size anodes and high in-vessel pressure lead to the peaking of the current profile around the anodes locations, and we experimentally characterized this effect. Instead, we found that anode radial position in the poloidal section has negligible effect on current density profile, even when the anodes are placed at the first wall. Finally, the most convenient operational regime, in terms of pressure and current, has been proposed. Keywords: RFX-mod, Glow discharge, Wall cleaning, Ion current profile, Anode desig

A Two-Phase Mass Flow Rate Model for Nitrous Oxide Based on Void Fraction

In the field of space propulsion, self pressurized technology is an example of innovation capable of improving system performances through reduction of volumes and other optimizations. Potential applications are widespread and not limited to the propulsion panorama: from on-orbit maneuvering to in-orbit servicing, from refueling of satellites at the end of life to in situ resource exploitation for missions headed towards remote objects of the solar system. However, important drawbacks have been reported for these systems: modeling of fluids and thermal phenomena is complex, thus preventing accurate performance predictions. As a result, no comprehensive and accurate model capable of describing the dynamics of a self-pressurizing propellant tank has been developed so far. In this context, this paper proposes a two-phase mass flow rate model based on void fraction. N2O has been selected due to its use as a green and self-pressurized propellant for in-space propulsive applications. The aim of this paper is to describe the current mass flow rate models present in the literature for this fluid and compare the new model with the one proposed by Dyer. A model validation is also offered, and a test campaign is mentioned. Finally, preliminary results are shown and discussed: results are then compared with the ones obtained through the Dyer model, in order to retrieve a comprehensive comparison among the two simulation frameworks. Comments on the results are added, showing the improvements as well as the limitations of the proposed framework

Efficacy of adalimumab as second-line therapy in a pediatric cohort of crohn’s disease patients who failed infliximab therapy: The Italian society of pediatric gastroenterology, hepatology, and nutrition experience

Background: Adalimumab (Ada) treatment is an available option for pediatric Crohn’s disease (CD) and the published experience as rescue therapy is limited. Objectives: We investigated Ada efficacy in a retrospective, pediatric CD cohort who had failed previous infliximab treatment, with a minimum follow-up of 6 months. Methods: In this multicenter study, data on demographics, clinical activity, growth, laboratory values (CRP) and adverse events were collected from CD patients during follow-up. Clinical remission (CR) and response were defined with Pediatric CD Activity Index (PCDAI) score ≤10 and a decrease in PCDAI score of ≥12.5 from baseline, respectively. Results: A total of 44 patients were consecutively recruited (mean age 14.8 years): 34 of 44 (77%) had active disease (mean PCDAI score 24.5) at the time of Ada administration, with a mean disease duration of 3.4 (range 0.3–11.2) years. At 6, 12, and 18 months, out of the total of the enrolled population, CR rates were 55%, 78%, and 52%, respectively, with a significant decrease in PCDAI scores (P<0.01) and mean CRP values (mean CRP 5.7 and 2.4 mL/dL, respectively; P<0.01) at the end of follow-up. Steroid-free remission rates, considered as the total number of patients in CR who were not using steroids at the end of this study, were 93%, 95%, and 96% in 44 patients at 6, 12, and 18 months, respectively. No significant differences in growth parameters were detected. In univariate analysis of variables related to Ada efficacy, we found that only a disease duration >2 years was negatively correlated with final PCDAI score (P<0.01). Two serious adverse events were recorded: 1 meningitis and 1 medulloblastoma. Conclusion: Our data confirm Ada efficacy in pediatric patients as second-line biological therapy after infliximab failure. Longer-term prospective data are warranted to define general effectiveness and safety in pediatric CD patients

Observation of interference between two distinct autoionizing states in dissociative photoionization of H 2

Dissociative photoionization (DPI) of randomly oriented H2 molecules has been studied using linearly polarized synchrotron radiation at selected photon energies of 31, 33, and 35 eV. Large amplitude oscillations in the photoelectron asymmetry parameter β, as a function of electron energy, have been observed. The phase of these β oscillations are in excellent agreement with the results of recent close coupling calculations [Fernández and Martín, New J. Phys. 11, 043020 (2009)]. We show that the oscillations are the signature of interferences between the 1Q1 Σu+1 and 1Q2 Πu1 doubly excited states decaying at different internuclear distances. The oscillations thus provide information about the classical paths followed by the nuclei. The presence of such oscillations is predicted to be a general phenomenon in DPIWe acknowledge NSERC, CLS, and UoW for their support. We thank Mare Nostrum BSC and CCC-UAM for allocation of computer time. Work partially supported by the MICINN Projects No. FIS2010-15127, No. ACI2008-0777, and No. CSD 2007-00010, the European MC-ITN CORINF, and the COST Action CM070

Tryptophan Metabolism as Source of New Prognostic Biomarkers for FAP Patients

Familial adenomatous polyposis (FAP), a common inherited form of colorectal cancer (CRC), causes the development of hundreds to thousands of colonic adenomas in the colorectum beginning in early adolescence. In absence of a prophylactic surgery, FAP patients almost inevitably develop CRC by the age of 40 to 50. The lack of valuable prognostic biomarkers for FAP patients makes it difficult to predict when the progression from adenoma to malignant carcinoma occurs. Decreased tryptophan (TRP) plasma levels and increased indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan hydroxylase 1 (TPH1) enzymatic activities have been associated to tumour progression in CRC. In the present study, we aimed at investigating whether an altered TRP metabolism might also exist in FAP patients. Our results highlighted that plasma levels of TRP and its main catabolites are comparable between FAP patients and healthy subject. On the contrary, FAP patients presented significantly higher TRP levels with respect to high-grade adenoma (ADE) subjects and CRC patients. Obtained data lead us to evaluate IDO1 and TPH1 enzymes activity in the study groups. For both enzymes, it was possible to discriminate correctly between FAP subject and ADE/CRC patients with high sensitivities and specificities. By receiver operating characteristic (ROC) curve analysis, the cut-off values of IDO1 and TPH1 enzymatic activities associated to the presence of an active malignant transformation have been calculated as >38 and >5.5, respectively. When these cut-off values are employed, the area under the curve (AUC) is > 0.8 for both, indicating that TRP metabolism in patients with FAP may be used to monitor and predict the tumorigenic evolution

Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis

Aim: To review and compare the PON-1 arylesterase activity between coronary artery disease (CAD) and non-CAD patients. Methods: Data were obtained by searching MEDLINE and Scopus for all investigations published between January 1, 2000 and March 1, 2021 comparing PON-1 arylesterase activity between CAD and controls. Results: Twenty studies, based on 5417 patients, met the inclusion criteria and were included in the analysis. A random effect model revealed that PON-1 arylesterase activity was significantly lower in the CAD group compared to controls (SMD = -0.587, 95%CI = -0.776 to -0.339, p < 0.0001, I2 = 92.3%). In CAD patients, the PON-1 arylesterase activity was significantly higher among CAD patients without diabetes mellitus (DM) compared to those with diabetes (SMD: 0.235, 95% CI: 0.014 to 0.456, p = 0.03, I2 = 0%). Conclusions: PON-1 activity is significantly lower in CAD patients, and those without DM presented a significantly higher PON-1 arylesterase activity